The Broken Machine: Why The U.S. Healthcare Costs More

This article frames the U.S. healthcare system as a malfunctioning economic engine, inviting readers to explore the policy failures and market distortions that make American healthcare uniquely costly.

INSIGHTS

enoma ojo (2025)

1/18/20266 min read

The Broken U.S Healthcare Machine
The Broken U.S Healthcare Machine

On a quiet Tuesday evening in Dallas, the Alvarez family sat around their kitchen table, bills spread out like a second set of burdens. Maria, a school bus driver, held the envelope from the hospital with trembling hands. Her husband, Daniel, had been rushed to the ER two months earlier after collapsing at work. The doctors saved his life, but the bill that followed threatened to break everything else. Their insurance covered part of the cost, but the remaining balance was more than their annual rent. The deductible alone was higher than the family’s savings. Their teenage daughter, Sofia, watched her parents whisper in worried tones, calculating what to delay: the car repair, the utility bill, or her college application fees. The choice felt cruel, but the math was unforgiving.

For the Alvarezes, healthcare was not a system of healing. It was a machine that demanded payment before offering relief. A machine that turned a medical emergency into a financial crisis. A machine that forced a hardworking family to choose between health and stability.

The Carter family lives in a small town tucked between the hills of eastern Kentucky, where the nearest hospital is more than an hour away, and the local clinic closes at 4 p.m. Most days, 72yearold Harold Carter manages his diabetes with quiet discipline, but when his vision began to blur, and his legs weakened, his wife, Ruth, knew something was wrong. They drove the long, winding road to the regional hospital, praying the old truck wouldn’t break down. The doctors stabilized him, but the bill that followed was devastating. Their Medicare plan covered part of the cost, but the outofpocket charges, ambulance fees, specialist consultations, and lab work swallowed nearly half of their monthly income. Harold joked that the hospital saved his life only to take the rest of it in payments. Ruth didn’t laugh. She had already begun rationing her own medications to help cover the debt.

In rural America, the Carters’ story is not unusual. Distance, scarcity of providers, and high costs collide to create a reality where survival depends as much on geography and money as on medicine. These two stories are not rare. It is not unusual. It is not an exception. It is the lived reality of millions of Americans navigating a system where the cost of care can be as frightening as the illness itself, and it raises a question at the heart of this article:

Why does the richest nation on earth make its people pay the highest price for the most basic human need, the chance to stay alive?

The United States spends more on healthcare than any other wealthy nation, far more, yet Americans do not enjoy better health outcomes. Total national health expenditures reached $4.5 trillion in 2022, and spending continues to rise faster than wages, inflation, and economic growth. In 2024 alone, healthcare spending grew 7.2%, hitting $5.3 trillion. This is not a glitch. It is the predictable output of a machine designed to reward cost, complexity, and consolidation rather than prevention, efficiency, or equity. The U.S. healthcare system is not “broken.” It is working exactly as built, just not for the people paying for it.

The United States spends more on healthcare than any other wealthy nation, yet Americans do not experience better health outcomes. This contradiction is the starting point for understanding a system that consumes trillions but delivers far less value than expected. Total national health expenditures reached $4.5 trillion in 2022, and by 2024, spending surged to $5.3 trillion. These numbers reflect a system where costs rise faster than wages, inflation, and economic growth, placing enormous pressure on families and employers. The core reason U.S. healthcare costs more is simple: prices are higher for nearly every service and product. Hospitals, physicians, and drug companies charge more, and insurers pass those costs directly to consumers.

Nearly 85% of every premium dollar goes toward hospital care, physician services, and prescription drugs. When these prices rise, premiums rise, a direct and unavoidable chain reaction that affects every insured American. Hospital consolidation is a major driver of rising costs. Threefourths of U.S. metro areas are now dominated by a small number of hospital systems, giving them the power to set higher prices without improving quality. When hospitals merge, prices increase because market power increases. This is not a sign of efficiency; it is a sign of monopoly dynamics operating under the label of healthcare. Administrative complexity adds another layer of cost. The U.S. system is fragmented, with multiple payers, inconsistent billing rules, and layers of intermediaries that create a massive administrative burden.

Unlike other wealthy nations that simplify billing and negotiate prices centrally, the U.S. maintains a maze of processes that add cost without adding value. This administrative overhead is a hidden tax on every patient and employer. The feeforservice payment model encourages volume over value. Providers are paid for the number of services they deliver, not the outcomes they achieve, incentivizing unnecessary tests, procedures, and visits. Researchers describe this as “lowvalue care”, services that increase spending without improving health. In a system built on volume, overuse is not an accident; it is a predictable outcome. Prescription drug pricing is another major cost driver. The U.S. allows drugmakers to set prices with minimal negotiation, leading Americans to pay more for the same medications than people in other countries.

Rising drug prices, expensive new therapies, and the surge in demand for weightloss medications are projected to significantly increase premiums in the coming years. The U.S. also carries a heavy burden of chronic disease, including diabetes, heart disease, and obesity. These conditions are expensive to manage and reflect a system that invests heavily in treatment but minimally in prevention. Political paralysis compounds the problem. Policymakers repeatedly diagnose the issues but fail to implement structural reforms because the most powerful stakeholders, hospitals, insurers, and pharmaceutical companies, benefit from the status quo. Ultimately, the U.S. healthcare system costs more because it is designed to cost more. High prices, consolidation, administrative complexity, and misaligned incentives are features of the system, not flaws. If America wants different outcomes, it must redesign the machine itself.

The U.S. healthcare system costs more because it is designed to cost more. High prices, consolidation, administrative complexity, misaligned incentives, and political paralysis are not accidents; they are the predictable outputs of a system optimized for revenue, not health. If America wants a different outcome, it must redesign the machine itself. Not with incremental fixes. Not with temporary patches, but with structural reform that aligns incentives with health, not profit. Until then, the U.S. will continue to spend more and get less, not because the system is broken, but because it is working exactly as intended.

The story of American healthcare is not a mystery. It is a mirror, reflecting a system built on prices that rise without restraint, institutions that consolidate without consequence, and incentives that reward volume over value. For decades, the nation has poured trillions into a machine that grows more expensive each year while delivering outcomes that lag behind its peers. The result is a system that consumes more than it heals, leaving families, employers, and communities to absorb the consequences. What makes this crisis especially painful is that it is not the product of ignorance. Policymakers, economists, and industry leaders have diagnosed the same structural failures again and again: high prices, administrative complexity, misaligned incentives, and chronic disease burdens that strain every part of the system. Yet recognition has rarely translated into reform. The machine continues to operate as designed, protected by the very stakeholders who profit from its inefficiencies.

Meanwhile, ordinary Americans face the human cost of this design. They delay care, ration medications, and navigate a maze of billing codes and insurance rules that feel engineered to exhaust rather than support them. Even those with insurance live with deductibles so high that coverage becomes a theoretical promise rather than a practical reality. In a nation with unmatched medical innovation, too many people experience healthcare as a source of financial fear rather than security. If the United States wants a different outcome, it must confront a simple truth: no amount of incremental adjustment will fix a system whose core incentives are misaligned with health. Real change requires redesigning the machine itself, aligning prices with value, simplifying administration, curbing consolidation, and investing in prevention with the same seriousness devoted to treatment. These are not radical ideas; they are the foundations of every highperforming healthcare system in the world.

The choice ahead is not technical. It is moral. A nation that spends more than any other on healthcare must decide whether it is willing to build a system worthy of that investment, one that treats health as a public good rather than a revenue opportunity. Until then, America will continue to pay more and get less, not because the system is broken, but because it is working exactly as intended. The question is whether we dare to build something better.

This conversation is bigger than policy; it’s about people. I welcome your reflections, your lived experiences, and your ideas for building a system worthy of the lives it serves.

All names and family stories in this article are fictional. Any resemblance to real individuals or events is purely coincidental.

© 2026 Inquiry & Insight by Enoma Ojo. All rights reserved.